DRKS00021504招募中不适用
Early intratracheal treatment with surfactant plus steroids (SurPluS) in low birth-weight premature infants following preterm premature rupture of the membranes-clincal course and outcome - SurPluS
niversität zu Lübeck0 个研究点目标入组 186 人开始时间: 2020年8月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 186
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 22 Pregnancy 至 32 Pregnancy（—）
- 性别
- All
入选标准
- •1.) Premature rupture of the membrans (>5 days)
- •2.) Oligohydramnios or anhydrmnios
- •3.) Severe respiratory distress syndrome in need of treatment with
- •a) surfatctant (controls)
- •b) surfactant and budenoside
排除标准
- •lethal malformations
研究者
相似试验
已完成
不适用
The effect of inhalant budesonide with surfactant prescription in the treatment of respiratory distress syndrome in premature infantsneonatal respiratory distress syndrome.Respiratory distress of newbornIRCT2017053034219N1Research Department of Jondi Shapoor University of Medical Sciences, Ahvaz74
已完成
3 期
Administration of budesonide with surfactant and prevention of bronchopulmonary dysplasiaIRCT20100512003915N20Tabriz University of Medical Sciences128
招募中
3 期
Concomitant intratracheal administration of surfactant and budesonide in the prevention of bronchopulmonary dysplasia (BPD)Condition 1: Bronchopulmonary dysplasia. Condition 2: Respiratory Distress syndrome.Bronchopulmonary dysplasia originating in the perinatal periodRespiratory distress syndrome of newbornP27.1P22.0IRCT20211107052993N1Iran University of Medical Sciences296
进行中（未招募）
1 期
Premedication for less invasive surfactant administratioEUCTR2018-002383-38-FIniversity of Oulu40
尚未招募
不适用
Effect of adding steroids to routine treatment in managing preterm babies with respiratory distressCTRI/2021/01/030392Susmitha Tangirala